FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1587788213> ?p ?o ?g. }

• W1587788213 endingPage "2061" @default.
• W1587788213 startingPage "2052" @default.
• W1587788213 abstract "This study investigated whether amphiregulin (AR), a ligand of the epidermal growth factor receptor (EGFR), improves liver regeneration after small-for-size liver transplantation. Livers of male C57BL/6 mice were reduced to ∼50% and ∼30% of original sizes and transplanted. After transplantation, AR and AR mRNA increased in 50% but not in 30% grafts. 5-Bromodeoxyuridine (BrdU) labeling, proliferating cell nuclear antigen (PCNA) expression and mitotic index increased substantially in 50% but not 30% grafts. Hyperbilirubinemia and hypoalbuminemia occurred and survival decreased after transplantation of 30% but not 50% grafts. AR neutralizing antibody blunted regeneration in 50% grafts whereas AR injection (5 μg/mouse, iv) stimulated liver regeneration, improved liver function and increased survival after transplantation of 30% grafts. Phosphorylation of EGFR and its downstream signaling molecules Akt, mTOR, p70S6K, ERK and JNK increased markedly in 50% but not 30% grafts. AR stimulated EGFR phosphorylation and its downstream signaling pathways. EGFR inhibitor PD153035 suppressed regeneration of 50% grafts and largely abrogated stimulation of regeneration of 30% grafts by AR. AR also increased cyclin D1 and cyclin E expression in 30% grafts. Together, liver regeneration is suppressed in small-for-size grafts, as least in part, due to decreased AR formation. AR supplementation could be a promising therapy to stimulate regeneration of partial liver grafts. This study investigated whether amphiregulin (AR), a ligand of the epidermal growth factor receptor (EGFR), improves liver regeneration after small-for-size liver transplantation. Livers of male C57BL/6 mice were reduced to ∼50% and ∼30% of original sizes and transplanted. After transplantation, AR and AR mRNA increased in 50% but not in 30% grafts. 5-Bromodeoxyuridine (BrdU) labeling, proliferating cell nuclear antigen (PCNA) expression and mitotic index increased substantially in 50% but not 30% grafts. Hyperbilirubinemia and hypoalbuminemia occurred and survival decreased after transplantation of 30% but not 50% grafts. AR neutralizing antibody blunted regeneration in 50% grafts whereas AR injection (5 μg/mouse, iv) stimulated liver regeneration, improved liver function and increased survival after transplantation of 30% grafts. Phosphorylation of EGFR and its downstream signaling molecules Akt, mTOR, p70S6K, ERK and JNK increased markedly in 50% but not 30% grafts. AR stimulated EGFR phosphorylation and its downstream signaling pathways. EGFR inhibitor PD153035 suppressed regeneration of 50% grafts and largely abrogated stimulation of regeneration of 30% grafts by AR. AR also increased cyclin D1 and cyclin E expression in 30% grafts. Together, liver regeneration is suppressed in small-for-size grafts, as least in part, due to decreased AR formation. AR supplementation could be a promising therapy to stimulate regeneration of partial liver grafts." @default.
• W1587788213 created "2016-06-24" @default.
• W1587788213 creator A5004628839 @default.
• W1587788213 creator A5023085512 @default.
• W1587788213 creator A5035890041 @default.
• W1587788213 creator A5046355482 @default.
• W1587788213 creator A5081078523 @default.
• W1587788213 creator A5084566693 @default.
• W1587788213 creator A5086765114 @default.
• W1587788213 date "2012-08-01" @default.
• W1587788213 modified "2023-10-16" @default.
• W1587788213 title "Amphiregulin Stimulates Liver Regeneration After Small-for-Size Mouse Liver Transplantation" @default.
• W1587788213 cites W1487125769 @default.
• W1587788213 cites W1495582545 @default.
• W1587788213 cites W1535697992 @default.
• W1587788213 cites W1967379823 @default.
• W1587788213 cites W1967542596 @default.
• W1587788213 cites W1971219973 @default.
• W1587788213 cites W1974565876 @default.
• W1587788213 cites W1976084529 @default.
• W1587788213 cites W1984975924 @default.
• W1587788213 cites W1986846416 @default.
• W1587788213 cites W1989105929 @default.
• W1587788213 cites W1989739477 @default.
• W1587788213 cites W1990132187 @default.
• W1587788213 cites W1992437153 @default.
• W1587788213 cites W1994866501 @default.
• W1587788213 cites W1995379683 @default.
• W1587788213 cites W1997126216 @default.
• W1587788213 cites W2000191817 @default.
• W1587788213 cites W2000539324 @default.
• W1587788213 cites W2000715689 @default.
• W1587788213 cites W2002378383 @default.
• W1587788213 cites W2008294451 @default.
• W1587788213 cites W2013507620 @default.
• W1587788213 cites W2015599978 @default.
• W1587788213 cites W2015978111 @default.
• W1587788213 cites W2016183531 @default.
• W1587788213 cites W2019917670 @default.
• W1587788213 cites W2023725015 @default.
• W1587788213 cites W2025070867 @default.
• W1587788213 cites W2031201632 @default.
• W1587788213 cites W2032344536 @default.
• W1587788213 cites W2043911313 @default.
• W1587788213 cites W2046186366 @default.
• W1587788213 cites W2059250453 @default.
• W1587788213 cites W2063034370 @default.
• W1587788213 cites W2065449203 @default.
• W1587788213 cites W2073367697 @default.
• W1587788213 cites W2075351969 @default.
• W1587788213 cites W2080192957 @default.
• W1587788213 cites W2084325067 @default.
• W1587788213 cites W2090157157 @default.
• W1587788213 cites W2093311859 @default.
• W1587788213 cites W2094673088 @default.
• W1587788213 cites W2095105178 @default.
• W1587788213 cites W2103382508 @default.
• W1587788213 cites W2109786285 @default.
• W1587788213 cites W2115162043 @default.
• W1587788213 cites W2116323570 @default.
• W1587788213 cites W2124403328 @default.
• W1587788213 cites W2124513090 @default.
• W1587788213 cites W2129469298 @default.
• W1587788213 cites W2130550745 @default.
• W1587788213 cites W2131035108 @default.
• W1587788213 cites W2132504508 @default.
• W1587788213 cites W2137293510 @default.
• W1587788213 cites W2137433095 @default.
• W1587788213 cites W2142113487 @default.
• W1587788213 cites W2149130539 @default.
• W1587788213 cites W2150508221 @default.
• W1587788213 cites W2155549216 @default.
• W1587788213 cites W2159728375 @default.
• W1587788213 cites W2163310352 @default.
• W1587788213 cites W3004882123 @default.
• W1587788213 cites W4237329722 @default.
• W1587788213 doi "https://doi.org/10.1111/j.1600-6143.2012.04069.x" @default.
• W1587788213 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3409348" @default.
• W1587788213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22694592" @default.
• W1587788213 hasPublicationYear "2012" @default.
• W1587788213 type Work @default.
• W1587788213 sameAs 1587788213 @default.
• W1587788213 citedByCount "20" @default.
• W1587788213 countsByYear W15877882132012 @default.
• W1587788213 countsByYear W15877882132013 @default.
• W1587788213 countsByYear W15877882132014 @default.
• W1587788213 countsByYear W15877882132015 @default.
• W1587788213 countsByYear W15877882132016 @default.
• W1587788213 countsByYear W15877882132017 @default.
• W1587788213 countsByYear W15877882132019 @default.
• W1587788213 countsByYear W15877882132020 @default.
• W1587788213 countsByYear W15877882132021 @default.
• W1587788213 countsByYear W15877882132023 @default.
• W1587788213 crossrefType "journal-article" @default.
• W1587788213 hasAuthorship W1587788213A5004628839 @default.
• W1587788213 hasAuthorship W1587788213A5023085512 @default.
• W1587788213 hasAuthorship W1587788213A5035890041 @default.
• W1587788213 hasAuthorship W1587788213A5046355482 @default.

• next